LT2395840T - Nitazoksanido kontroliuojamo atpalaidavimo farmacinės kompozicijos - Google Patents
Nitazoksanido kontroliuojamo atpalaidavimo farmacinės kompozicijosInfo
- Publication number
- LT2395840T LT2395840T LTEP10741758.6T LT10741758T LT2395840T LT 2395840 T LT2395840 T LT 2395840T LT 10741758 T LT10741758 T LT 10741758T LT 2395840 T LT2395840 T LT 2395840T
- Authority
- LT
- Lithuania
- Prior art keywords
- nitazoxanide
- controlled release
- pharmaceutical formulations
- release pharmaceutical
- formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20228509P | 2009-02-13 | 2009-02-13 | |
PCT/US2010/024000 WO2010093854A1 (en) | 2009-02-13 | 2010-02-12 | Controlled release pharmaceutical formulations of nitazoxanide |
Publications (1)
Publication Number | Publication Date |
---|---|
LT2395840T true LT2395840T (lt) | 2020-07-10 |
Family
ID=42560126
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LTEP10741758.6T LT2395840T (lt) | 2009-02-13 | 2010-02-12 | Nitazoksanido kontroliuojamo atpalaidavimo farmacinės kompozicijos |
Country Status (23)
Country | Link |
---|---|
US (5) | US8524278B2 (lt) |
EP (1) | EP2395840B1 (lt) |
JP (3) | JP5726766B2 (lt) |
KR (1) | KR101697800B1 (lt) |
CN (2) | CN102395276A (lt) |
AU (3) | AU2010213678B2 (lt) |
BR (1) | BRPI1007945C8 (lt) |
CA (1) | CA2752233C (lt) |
CO (1) | CO6501159A2 (lt) |
CY (1) | CY1123162T1 (lt) |
DK (1) | DK2395840T3 (lt) |
EA (1) | EA029018B1 (lt) |
ES (1) | ES2797493T3 (lt) |
HR (1) | HRP20201055T1 (lt) |
HU (1) | HUE049501T2 (lt) |
IL (1) | IL214624A0 (lt) |
LT (1) | LT2395840T (lt) |
MX (1) | MX348282B (lt) |
PL (1) | PL2395840T3 (lt) |
PT (1) | PT2395840T (lt) |
SI (1) | SI2395840T1 (lt) |
UA (1) | UA107564C2 (lt) |
WO (1) | WO2010093854A1 (lt) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA200806310B (en) * | 2006-01-09 | 2009-12-30 | Romark Lab Lc | Viral hepatitis treatment |
JP5726766B2 (ja) * | 2009-02-13 | 2015-06-03 | ロマーク ラボラトリーズ エル.シー. | ニタゾキサニドの制御放出医薬配合物 |
BR112014018149B1 (pt) | 2012-01-27 | 2020-09-29 | Siegfried Rhein S.A. De C.V | Composição farmacêutica de nitazoxanida |
US20150017242A1 (en) * | 2012-02-20 | 2015-01-15 | Lupin Limited | Bilayer Tablet of Dronedarone |
KR101639692B1 (ko) * | 2013-12-13 | 2016-07-14 | 제일약품주식회사 | 2 이상의 유효성분을 포함하는 구강 내 속붕해 다중유닛 약제학적 조성물 |
CN107105660A (zh) | 2014-11-11 | 2017-08-29 | 罗马克实验室有限公司 | 使用替唑尼特、其类似物或盐的前药的治疗组合物和治疗方法 |
PL3436074T3 (pl) | 2016-03-31 | 2020-11-02 | Romark Laboratories, L.C. | Związki z grupą tiazolidynową do leczenia zakażeń wirusowych |
MX2018012285A (es) * | 2016-04-11 | 2019-02-07 | Genfit | Metodos de tratamiento para enfermedades colestasicas y fibroticas. |
US10905680B2 (en) * | 2016-04-11 | 2021-02-02 | Genfit | Methods of treatment for cholestatic and fibrotic diseases |
CN110381925A (zh) * | 2017-03-08 | 2019-10-25 | 辛瑞克斯制药有限公司 | 间苯三酚和三甲基间苯三酚的药物制剂 |
US11191749B2 (en) * | 2017-03-13 | 2021-12-07 | Genfit | Pharmaceutical compositions for combination therapy |
US11173149B2 (en) | 2017-04-18 | 2021-11-16 | Romark Laboratories L.C. | Inhibition of protein disulfide-isomerase A3 |
EP3639855A4 (en) * | 2017-06-16 | 2021-03-17 | The Doshisha | COMPOUNDS HAVING CASPASE INHIBITORING ACTIVITY, PHARMACEUTICAL AGENT CONTAINING THEM FOR THE TREATMENT OR PREVENTION OF SYMPTOMS, DISORDERS OR DISEASES OF CORNEAL ENDOTHELIUM, AND APPLICATION OF SUCH PHARMACEUTICAL AGENT |
WO2018230711A1 (ja) | 2017-06-16 | 2018-12-20 | 学校法人同志社 | mTORインヒビターを含む、眼の症状、障害または疾患を治療または予防するための医薬およびその応用 |
CN108524460B (zh) * | 2018-05-14 | 2021-01-01 | 佛山市南海东方澳龙制药有限公司 | 烯啶虫胺双层片 |
CN110025621A (zh) * | 2019-03-13 | 2019-07-19 | 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) | 替唑尼特和硝唑尼特在制备抗炎药物中的应用 |
CN111012788B (zh) * | 2019-12-12 | 2021-01-15 | 武汉职业技术学院 | 硝唑尼特和替唑尼特在制备抗猪繁殖与呼吸综合征病毒药物中的应用 |
CN114845704A (zh) * | 2019-12-19 | 2022-08-02 | 赛特瑞恩股份有限公司 | 包含西苯唑啉或其盐的药物制剂 |
WO2022020243A1 (en) | 2020-07-20 | 2022-01-27 | Romark Laboratories L.C. | Crystalline salts of tizoxanide and 2-hydroxy-n-(5-chloro-1,3-thiazol-2-yl)benzamide (rm-4848) with ethanolamine, morpholine, propanolamine, piperazine and n-methylpiperazine |
AU2021333566A1 (en) | 2020-08-24 | 2023-03-16 | Romark Laboratories L.C. | Use of thiazolides against coronaviruses |
WO2022130406A1 (en) * | 2020-12-15 | 2022-06-23 | Cipla Limited | Inhalation composition of nitazoxanide or its derivatives for use in coronavirus disease |
CN114259492A (zh) * | 2021-12-21 | 2022-04-01 | 中以海德人工智能药物研发股份有限公司 | 硝唑尼特在治疗乙肝中的应用 |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1437800A (en) | 1973-08-08 | 1976-06-03 | Phavic Sprl | Derivatives of 2-benzamido-5-nitro-thiazoles |
JPH06316517A (ja) * | 1993-02-22 | 1994-11-15 | Grelan Pharmaceut Co Ltd | 放出制御製剤 |
US5387598A (en) * | 1994-04-13 | 1995-02-07 | Rossignol; Jean-Francois | Composition and galenic formulation suitable for combatting affections of the lower abdomen |
US5578621A (en) * | 1994-09-08 | 1996-11-26 | Romark Lab Lc | Benzamide derivatives |
MX9604483A (es) * | 1994-09-08 | 1998-02-28 | Jean-Francois Rossignol | Derivados de benzamida, composiciones que contienen dicho derivado y uso de las mismas. |
US5968961A (en) | 1997-05-07 | 1999-10-19 | Romark Laboratories, L.C. | Pharmaceutical compositions of tizoxanide and nitazoxanide |
AU740022B2 (en) * | 1997-05-07 | 2001-10-25 | Romark Laboratories, L.C. | Pharmaceutical compositions of tizoxanide and nitazoxanide |
US5948440A (en) | 1997-12-17 | 1999-09-07 | Ranbaxy Laboratories Limited | Modified release matrix formulation of cefaclor and cephalexin |
RU2236847C2 (ru) | 1998-11-02 | 2004-09-27 | Илан Корпорейшн, Плк. | Композиции в виде множества частиц с модифицированным высвобождением |
GB0009522D0 (en) * | 2000-04-19 | 2000-06-07 | Smithkline Beecham Plc | Composition |
DE10031043A1 (de) * | 2000-06-26 | 2002-02-14 | Bayer Ag | Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung |
JP4637338B2 (ja) | 2000-09-22 | 2011-02-23 | 大塚製薬株式会社 | シロスタゾール有核錠 |
RU2285519C2 (ru) | 2000-09-29 | 2006-10-20 | Солвей Фармасьютикалс Б.В. | Фармацевтическая композиция с пролонгированным высвобождением, независимым от ионной силы |
US7074417B2 (en) | 2000-10-13 | 2006-07-11 | Advancis Pharmaceutical Corporation | Multiple-delayed release anti-viral product, use and formulation thereof |
PL370818A1 (en) | 2001-09-28 | 2005-05-30 | Sun Pharmaceutical Industries Limited | Dosage form for treatment of diabetes mellitus |
JP2005509604A (ja) * | 2001-09-28 | 2005-04-14 | マクニール−ピーピーシー・インコーポレイテッド | 菓子組成物を含む剤形 |
US7985422B2 (en) * | 2002-08-05 | 2011-07-26 | Torrent Pharmaceuticals Limited | Dosage form |
UY28457A1 (es) | 2003-08-07 | 2005-03-31 | Sb Pharmco Inc | Nueva composición |
GB0319874D0 (en) * | 2003-08-22 | 2003-09-24 | Glaxo Group Ltd | Novel formulation |
UA90864C2 (en) * | 2004-09-09 | 2010-06-10 | Ромарк Лебораториз, Л.К. | Halogenated benzamide derivatives |
WO2006070406A1 (en) * | 2004-12-29 | 2006-07-06 | J.B. Chemicals & Pharmaceuticals Ltd | Bilayer tablets of oxcarbazepine for controlled delivery and a process of preparation thereof |
CA2604640A1 (en) * | 2005-04-12 | 2006-10-19 | Romark Laboratories L.C. | Methods for treating diseases through interruption of protein maturation, compounds that inhibit the function of molecular chaperones such as protein disulfide isomerases or interfere with glycosylation, pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents |
FR2889811B1 (fr) | 2005-08-19 | 2009-10-09 | Sanofi Aventis Sa | Association d'un agent hypnotique a duree d'action longue et d'un agent hypnotique a duree d'action courte, composition pharmaceutique la contenant et son application en therapeutique. |
ZA200806310B (en) * | 2006-01-09 | 2009-12-30 | Romark Lab Lc | Viral hepatitis treatment |
JP2006335771A (ja) * | 2006-09-22 | 2006-12-14 | Takeda Chem Ind Ltd | 徐放性製剤およびその製造方法 |
US20080299188A1 (en) * | 2007-05-14 | 2008-12-04 | Pfizer Inc. | Controlled release dosage forms combining immediate release and sustainted release of low-solubility drug |
US20080286344A1 (en) * | 2007-05-16 | 2008-11-20 | Olivia Darmuzey | Solid form |
PT2178852E (pt) * | 2007-08-03 | 2015-11-12 | Romark Lab Lc | Compostos tiazolida substituídos com alquilsulfonilo |
JP5726766B2 (ja) * | 2009-02-13 | 2015-06-03 | ロマーク ラボラトリーズ エル.シー. | ニタゾキサニドの制御放出医薬配合物 |
-
2010
- 2010-02-12 JP JP2011550246A patent/JP5726766B2/ja active Active
- 2010-02-12 CN CN2010800164251A patent/CN102395276A/zh active Pending
- 2010-02-12 CA CA2752233A patent/CA2752233C/en not_active Expired - Fee Related
- 2010-02-12 EA EA201190127A patent/EA029018B1/ru not_active IP Right Cessation
- 2010-02-12 LT LTEP10741758.6T patent/LT2395840T/lt unknown
- 2010-02-12 HU HUE10741758A patent/HUE049501T2/hu unknown
- 2010-02-12 KR KR1020117020973A patent/KR101697800B1/ko active IP Right Grant
- 2010-02-12 EP EP10741758.6A patent/EP2395840B1/en active Active
- 2010-02-12 MX MX2011008530A patent/MX348282B/es active IP Right Grant
- 2010-02-12 US US12/656,704 patent/US8524278B2/en not_active Expired - Fee Related
- 2010-02-12 SI SI201032014T patent/SI2395840T1/sl unknown
- 2010-02-12 PL PL10741758T patent/PL2395840T3/pl unknown
- 2010-02-12 WO PCT/US2010/024000 patent/WO2010093854A1/en active Application Filing
- 2010-02-12 ES ES10741758T patent/ES2797493T3/es active Active
- 2010-02-12 BR BRPI1007945A patent/BRPI1007945C8/pt not_active IP Right Cessation
- 2010-02-12 CN CN201710263825.6A patent/CN107260695A/zh active Pending
- 2010-02-12 AU AU2010213678A patent/AU2010213678B2/en not_active Ceased
- 2010-02-12 DK DK10741758.6T patent/DK2395840T3/da active
- 2010-02-12 PT PT107417586T patent/PT2395840T/pt unknown
- 2010-12-02 UA UAA201110567A patent/UA107564C2/uk unknown
-
2011
- 2011-08-11 IL IL214624A patent/IL214624A0/en active IP Right Grant
- 2011-09-07 CO CO11115308A patent/CO6501159A2/es not_active Application Discontinuation
-
2013
- 2013-07-30 US US13/954,184 patent/US9351937B2/en active Active
-
2015
- 2015-04-01 JP JP2015075264A patent/JP6117845B2/ja active Active
-
2016
- 2016-02-16 AU AU2016200971A patent/AU2016200971B2/en not_active Ceased
- 2016-04-29 US US15/141,921 patent/US9827227B2/en active Active - Reinstated
- 2016-12-09 JP JP2016239374A patent/JP6491174B2/ja active Active
-
2017
- 2017-05-11 AU AU2017203148A patent/AU2017203148B2/en not_active Ceased
- 2017-11-16 US US15/814,850 patent/US10383855B2/en active Active
-
2019
- 2019-07-02 US US16/460,161 patent/US11426388B2/en active Active
-
2020
- 2020-07-03 HR HRP20201055TT patent/HRP20201055T1/hr unknown
- 2020-07-07 CY CY20201100626T patent/CY1123162T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL214624A0 (en) | Controlled release pharmaceutical formulations of nitazoxanide | |
HRP20181755T1 (hr) | Formulacije tableta s trenutnim oslobađanjem | |
ZA201208336B (en) | Controlled release pharmaceutical compositions of tapentadol | |
EP2509634A4 (en) | STABLE FORMULATIONS FOR LYOPHILIZATION THERAPEUTIC PARTICLES | |
IL217153A0 (en) | Controlled release formulations | |
PT2482812T (pt) | Composições farmacêuticas compreendendo bi-1356 e metformina | |
HUE062860T2 (hu) | Magas koncentrációjú gyógyszerészeti készítmények | |
PL2515941T3 (pl) | Preparat farmaceutyczny zawierający bewacyzumab | |
HK1169960A1 (en) | Pharmaceutical formulation | |
EP2500038A4 (en) | PHATMACEUTICAL COMPOSITION FOR EXTERNAL USE / | |
PT2408446T (pt) | Utilização de composições farmacêuticas contendo mesembrenona | |
IL219155A0 (en) | Pharmaceutical formulations of nitrite and uses thereof | |
PL2554168T3 (pl) | Kompozycja farmaceutyczna do kontrolowanego uwalniania | |
ZA201107122B (en) | Stable pharmaceutical compositions of diclofenac | |
ZA201200659B (en) | Pharmaceutical composition of isoniazid | |
PL2391352T3 (pl) | Formy farmaceutyczne stosowane do uwalniania związków aktywnych | |
EP2405754A4 (en) | PHARMACEUTICAL BUPRENORPHINE COMPOSITIONS WITH MODIFIED RELEASE | |
EP2471519A4 (en) | CARVEDILOL FORMULATION WITH CONTROLLED RELEASE | |
EP2473168A4 (en) | PHARMACEUTICAL FORMULATIONS FOR INDIBULIN | |
ZA201200531B (en) | Pharmaceutical composition of rifampicin | |
HU1000224D0 (en) | Pharmaceutical composition of controlled release | |
GB0914989D0 (en) | Drug release formulations | |
GB201001335D0 (en) | Drug release formulations |